Leadership | Amgen

SENIOR MANAGEMENT
BOARD OF DIRECTORS
SCIENTIFIC ADVISORY BOARDS

Senior Management

Robert A. Bradway

Chairman and Chief Executive Officer

James Bradner

Executive Vice President, Research and Development

Sean Bruich

Senior Vice President Artificial Intelligence and Data

Paul Burton

Senior Vice President and Chief Medical Officer

Howard Chang

Senior Vice President, Global Research, and Chief Scientific Officer

Jackie Elbonne

Senior Vice President, Quality and Chief Quality Officer

Murdo Gordon

Executive Vice President, Global Commercial Operations

Jonathan Graham

Executive Vice President and General Counsel and Secretary

Peter Griffith

Executive Vice President and Chief Financial Officer

Nancy Grygiel

Senior Vice President, Worldwide Compliance & Business Ethics and Chief Compliance Officer

Sam Guhan

Senior Vice President, Global Engineering

Narimon Honarpour

Senior Vice President, Global Development

My Linh Kha

Senior Vice President and General Manager, Japan Asia-Pacific

Rachna Khosla

Senior Vice President, Business Development

Gilles Marrache

Senior Vice President, Regional General Manager

Derek Miller

Senior Vice President, Human Resources

Jerry Murry

Senior Vice President, Process Development

Kave Niksefat

Senior Vice President, Global Marketing and Access

Arleen Paulino

Senior Vice President, Manufacturing

Annalisa Pizzarello

Senior Vice President, Results Delivery Office

Greg Portner

Senior Vice President, Global Government Affairs and Policy

Emily Razaqi

Senior Vice President, Obesity and Related Conditions

David M. Reese

Executive Vice President and Chief Technology Officer

Esteban Santos

Executive Vice President, Operations

Scott Skellenger

Senior Vice President and Chief Information Officer

Darryl Sleep

Senior Vice President, Global Medical

Jean-Charles Soria

Senior Vice President, Research and Development

Susan Sweeney

Executive Vice President, Obesity and Related Conditions

Mark J. Taisey

Senior Vice President, Global Regulatory Affairs and Strategy

Susie Tappouni

Head of Corporate Affairs

Ian Thompson

Senior Vice President, U.S. Business Operations

Brenda Torres

Senior Vice President, Global Supply Chain

Alper Üreten

Vice President, Commercialization and Program Management

Jasper van Grunsven

Senior Vice President, Rare Disease

Board of Directors

Wanda M. Austin

Retired President and Chief Executive Officer, The Aerospace Corporation

Robert A. Bradway

Chairman and Chief Executive Officer, Amgen Inc.

Michael V. Drake

President, University of California

Brian J. Druker

Physician-Scientist and Professor of Medicine, Oregon Health & Science University (OHSU), Director of the OHSU Knight Cancer Institute and JELD-WEN Chair of Leukemia Research, and Associate Dean for Oncology, OHSU School of Medicine

Robert A. Eckert (Lead Independent Director)

Chairman Emeritus, Mattel, Inc.

Greg C. Garland

Former Executive Chairman and Former Chairman and Chief Executive Officer, Phillips 66

Charles M. Holley, Jr.

Former Executive Vice President and Chief Financial Officer of Wal-Mart Stores, Inc.

S. Omar Ishrak

Former Executive Chairman and Chairman of the Board of Directors, Medtronic plc

Tyler Jacks

David H. Koch Professor of Biology, Massachusetts Institute of Technology and Founding Director of the David H. Koch Institute for Integrative Cancer Research

Mary E. Klotman

Executive Vice President for Health Affairs of Duke University, Dean of the Duke University School of Medicine, and Chief Academic Officer of Duke Health

Ellen J. Kullman

Executive Chair of the Board and Former President and Chief Executive Officer of Carbon, Inc.

Amy E. Miles

Former Chair of the Board and Chief Executive Officer, Regal Entertainment Group, Inc.

Scientific Advisory Boards

At Amgen, we recognize that innovation comes from many sources. The formation of the Amgen Scientific Advisory Boards formalizes our belief in engaging outside experts to help us theorize, test and spur our discovery and development processes forward. The Scientific Advisory Boards provide external scientific review of our research and development activities and assist management in making significant scientific judgments.

CO-CHAIRS

Elliott Sigal, MD, PhD

Advisor & Board Member in Biotechnology
Former Chief Scientific Officer, Bristol-Myers Squibb

David Baltimore, PhD

President Emeritus and Distinguished Professor of Biology, California Institute of Technology

Research Trends and Emerging Technologies

David J. Anderson, PhD

California Institute of Technology, Howard Hughes Medical Institute

Ron Evans, PhD

Salk Institute, National Academy of Sciences, Institute of Medicine

George Georgiou, PhD

Dula D. Cockrell Centennial Chair Professor at UT Austin

Richard O. Hynes, PhD, FRS

Koch Institute and Department of Biology at MIT, Broad Institute

John Kuriyan, PhD

Vanderbilt University School of Medicine

Frank McCormick, PhD

University California San Francisco, Helen Diller Family Comprehensive Cancer Center

Ruslan Medzhitov, PhD

Yale University School of Medicine, Howard Hughes Medical Institute

Robert Tjian, PhD

University of California, Berkeley, Howard Hughes Medical Institute

Jonathan S. Weissman, PhD

Whitehead Institute and MIT, Howard Hughes Medical Institute

Cardiovascular and Metabolic

E. Dale Abel, MD, PhD

David Geffen School of Medicine, University of California at Los Angeles and UCLA Health

Daniel Drucker, MD, FRPCP

Lunenfeld Tanenbaum Research Institute, Toronto, Canada

David Alan Kass, MD

The Johns Hopkins University School of Medicine

Daniel P. Kelly, MD

Perelman School of Medicine, University of Pennsylvania

Peter Libby, MD

Harvard Medical School, Brigham and Women's Hospital

Jeff D. Molkentin, PhD

Cincinnati Children's Hospital Medical Center

Thomas Quertermous, MD

William G. Irwin Professor of Medicine, Stanford University

Marlene Rabinovitch, MD

Stanford School of Medicine

R. Sanders Williams, MD

Duke University, Professor of Medicine and Senior Advisor for Science & Technology

Oncology

Fabrice André, MD, PhD

Institut Gustave Roussy, Villejuif, France

S. Gail Eckhardt, MD, FASCO

Baylor College of Medicine

Siwen Hu-Lieskovan, MD, PhD

University of Utah, School of Medicine

Dirk Jager, PhD

Managing Director, NCT Heidelberg

Robert Negrin, MD

Stanford School of Medicine

Drew Pardoll, MD, PhD

The Johns Hopkins University School of Medicine

Antoni Ribas MD, PhD

University of California at Los Angeles Medical Center

Lillian L. Siu, MD

Princess Margaret Cancer Center, Toronto, Canada

Benoit Van den Eynde, MD, PhD

Ludwig Institute for Cancer Research, de Duve Institute, Brussels

Inflammation

Maria Abreu, MD

Vice President, American Gastroenterological Association (AGA), Professor of Medicine, University of Miami Miller School of Medicine

Emma Guttman, MD, PhD

Waldman Professor of Dermatology & Immunology, Icahn School of Medicine at Mount Sinai, New York

Meilan Han, MD, MS

Professor of Medicine, Chief, Division of Pulmonary & Critical Care, University of Michigan

Alexander Marson, MD, PhD

Director, Gladstone-UCSF Institute of Genomic Immunology, UCSF

Diane Mathis, PhD

Harvard Medical School

Alexander (Sasha) Rudensky, PhD

Chair, SKI Immunology Program, Director, Ludwig Center, Memorial Sloan Kettering, Howard Hughes Medical Institute

Arlene Sharpe, MD, PhD

George Fabyan Professor of Comparative Pathology, Chair of the Department of Immunology, Harvard Medical School

Dean Sheppard, MD

Professor of Medicine, UCSF